IDEXX Laboratories, Inc. (OQ:IDXX)

Business Focus: Veterinary Medical Equipment & Supplies

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for IDXX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Ayers Jonathan W Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Non-Qualified Stock Option (right-to-buy) M - Exercise or conversion exempt under rule 16b-3 -13,824  
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -388 $281.97
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -100 $280.13
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -1,676 $279.01
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -3,354 $277.88
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -1,337 $276.71
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -1,145 $275.72
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 13,824 $45.84
Feb 3/20 Jan 30/20 Vandebroek Sophie V. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 70 $283.73
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for IDXX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 17th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Ayers Jonathan W Indirect Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities    
Feb 14/20 Nov 18/19 Ayers Jonathan W Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -3,860  
Feb 14/20 Nov 18/19 Ayers Jonathan W Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -17,300  
Feb 14/20 Nov 18/19 Ayers Jonathan W Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -1,800  
Feb 14/20 Aug 8/19 Ayers Jonathan W Direct Ownership Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -15,000  
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Non-Qualified Stock Option (right-to-buy) M - Exercise or conversion exempt under rule 16b-3 -13,824  
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -388 $281.97
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -100 $280.13
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -1,676 $279.01
Feb 7/20 Feb 5/20 Mazelsky Jonathan Jay Direct Ownership Common Stock S - Open market or private sale -3,354 $277.88
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $IDXX

Competitors

Competitors with Recent Insider Filings
No competitors with recent insider filings.